SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060509
Filing Date
2013-11-12
Accepted
2013-11-12 16:07:16
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v358320_10q.htm 10-Q 533648
2 EXHIBIT 31.1 v358320_ex31-1.htm EX-31.1 8373
3 EXHIBIT 31.2 v358320_ex31-2.htm EX-31.2 8220
4 EXHIBIT 32.1 v358320_ex32-1.htm EX-32.1 4297
5 EXHIBIT 32.2 v358320_ex32-2.htm EX-32.2 3727
  Complete submission text file 0001144204-13-060509.txt   4668065

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20130930.xml EX-101.INS 515737
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20130930.xsd EX-101.SCH 48699
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20130930_cal.xml EX-101.CAL 66243
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20130930_def.xml EX-101.DEF 146709
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20130930_lab.xml EX-101.LAB 687994
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20130930_pre.xml EX-101.PRE 304583
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 131210213
SIC: 2836 Biological Products, (No Diagnostic Substances)